chr17-80050062-A-G
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_017950.4(CCDC40):c.940-2A>G variant causes a splice acceptor, intron change. The variant allele was found at a frequency of 0.0000242 in 1,613,754 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_017950.4 splice_acceptor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CCDC40 | NM_017950.4 | c.940-2A>G | splice_acceptor_variant, intron_variant | Intron 6 of 19 | ENST00000397545.9 | NP_060420.2 | ||
CCDC40 | NM_001243342.2 | c.940-2A>G | splice_acceptor_variant, intron_variant | Intron 6 of 17 | NP_001230271.1 | |||
CCDC40 | NM_001330508.2 | c.940-2A>G | splice_acceptor_variant, intron_variant | Intron 6 of 10 | NP_001317437.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 151906Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000160 AC: 4AN: 249448Hom.: 0 AF XY: 0.0000222 AC XY: 3AN XY: 135378
GnomAD4 exome AF: 0.0000260 AC: 38AN: 1461848Hom.: 0 Cov.: 34 AF XY: 0.0000275 AC XY: 20AN XY: 727234
GnomAD4 genome AF: 0.00000658 AC: 1AN: 151906Hom.: 0 Cov.: 31 AF XY: 0.0000135 AC XY: 1AN XY: 74178
ClinVar
Submissions by phenotype
Primary ciliary dyskinesia Pathogenic:3
The c.940-2A>G variant in CCDC40 has been previously reported in 2 compound hete rozygous individuals with primary ciliary dyskinesia (PCD) who carried pathogeni c CCDC40 variants in trans (Becker-Heck 2011, Antony2013). This variant has been identified in 2/66492 Non-Finnish European chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org). Although this variant has be en seen in the general population, its frequency is low enough to be consistent with a recessive carrier frequency. This variant occurs in the invariant region (+/- 1,2) of the splice consensus sequence and is predicted to cause altered spl icing leading to an abnormal or absent protein. Functional studies indicate that loss of CCDC40 function results in abnormal cilia structure and motility (Becke r-Heck 2011). In summary, this variant meets our criteria to be classified as pa thogenic for PCD in an autosomal recessive manner (http://www.partners.org/perso nalizedmedicine/LMM) based upon the predicted impact to protein and multiple co- occurrences with other pathogenic variants. -
- -
This sequence change affects an acceptor splice site in intron 6 of the CCDC40 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in CCDC40 are known to be pathogenic (PMID: 21131974, 22693285, 23255504). This variant is present in population databases (rs750708201, gnomAD 0.004%). Disruption of this splice site has been observed in individual(s) with primary ciliary dyskinesia (PMID: 23255504; internal datadatabase). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 228326). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at